ALX Oncology Holdings Q4 Adj. EPS $(0.37) Misses $(0.36) Estimate
ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.36) by 2.21 percent. This is a 15.91 percent increase over losses of $(0.44) per share